On Target Laboratories

On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue Universitys Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete...

Flourescence guided surgery,intra-operative optical imaging for cancer,oncology,surgery,cancer,fluorescent imaging technology,intraoperative sight,science,ovarian cancer,lung cancer,prostate cancer,and thoracic surgery

On target laboratories's revenue is 11m - 100m

On target laboratories has 11 - 50 employees.